IMD INTERNATIONAL MEDICAL DE (IMD.MI) Stock Fundamental Analysis
Europe - BIT:IMD - IT0005549255 - Common Stock
1.5 EUR
-0.02 (-1.32%)
IMD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 60 industry peers in the Health Care Equipment & Supplies industry. IMD has a great financial health rating, but its profitability evaluates not so good. IMD has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
IMD had positive earnings in the past year.
In the past year IMD had a positive cash flow from operations.
1.2 Ratios
IMD has a better Return On Assets (4.04%) than 63.93% of its industry peers.
The Return On Equity of IMD (6.09%) is comparable to the rest of the industry.
IMD's Return On Invested Capital of 4.85% is in line compared to the rest of the industry. IMD outperforms 47.54% of its industry peers.
IMD had an Average Return On Invested Capital over the past 3 years of 12.28%. This is above the industry average of 8.99%.
The last Return On Invested Capital (4.85%) for IMD is well below the 3 year average (12.28%), which needs to be investigated, but indicates that IMD had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.04% | ||
| ROE | 6.09% | ||
| ROIC | 4.85% |
ROA(3y)7.1%
ROA(5y)N/A
ROE(3y)13.65%
ROE(5y)N/A
ROIC(3y)12.28%
ROIC(5y)N/A
1.3 Margins
With a Profit Margin value of 3.70%, IMD perfoms like the industry average, outperforming 50.82% of the companies in the same industry.
In the last couple of years the Profit Margin of IMD has declined.
IMD has a worse Operating Margin (4.83%) than 62.30% of its industry peers.
In the last couple of years the Operating Margin of IMD has declined.
IMD has a Gross Margin of 24.88%. This is amonst the worse of the industry: IMD underperforms 86.89% of its industry peers.
In the last couple of years the Gross Margin of IMD has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.83% | ||
| PM (TTM) | 3.7% | ||
| GM | 24.88% |
OM growth 3Y-15.05%
OM growth 5YN/A
PM growth 3Y-13.98%
PM growth 5YN/A
GM growth 3Y-1.7%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), IMD is creating some value.
The number of shares outstanding for IMD remains at a similar level compared to 1 year ago.
IMD has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.04 indicates that IMD is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.04, IMD is in the better half of the industry, outperforming 72.13% of the companies in the same industry.
IMD has a debt to FCF ratio of 0.19. This is a very positive value and a sign of high solvency as it would only need 0.19 years to pay back of all of its debts.
IMD has a better Debt to FCF ratio (0.19) than 95.08% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that IMD is not too dependend on debt financing.
The Debt to Equity ratio of IMD (0.01) is better than 91.80% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.19 | ||
| Altman-Z | 4.04 |
ROIC/WACC0.61
WACC8.02%
2.3 Liquidity
IMD has a Current Ratio of 3.53. This indicates that IMD is financially healthy and has no problem in meeting its short term obligations.
IMD has a better Current ratio (3.53) than 90.16% of its industry peers.
A Quick Ratio of 1.74 indicates that IMD should not have too much problems paying its short term obligations.
IMD has a better Quick ratio (1.74) than 72.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.53 | ||
| Quick Ratio | 1.74 |
3. Growth
3.1 Past
The earnings per share for IMD have decreased strongly by -48.43% in the last year.
The earnings per share for IMD have been decreasing by -17.97% on average. This is quite bad
IMD shows a decrease in Revenue. In the last year, the revenue decreased by -5.61%.
The Revenue has been decreasing by -5.22% on average over the past years.
EPS 1Y (TTM)-48.43%
EPS 3Y-17.97%
EPS 5YN/A
EPS Q2Q%-66.28%
Revenue 1Y (TTM)-5.61%
Revenue growth 3Y-5.22%
Revenue growth 5YN/A
Sales Q2Q%-15.36%
3.2 Future
The Earnings Per Share is expected to decrease by -6.27% on average over the next years.
Based on estimates for the next years, IMD will show a small growth in Revenue. The Revenue will grow by 1.81% on average per year.
EPS Next Y-23.53%
EPS Next 2Y-9.25%
EPS Next 3Y-6.27%
EPS Next 5YN/A
Revenue Next Year0.61%
Revenue Next 2Y1.52%
Revenue Next 3Y1.81%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 18.75, which indicates a rather expensive current valuation of IMD.
77.05% of the companies in the same industry are more expensive than IMD, based on the Price/Earnings ratio.
IMD's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.51.
IMD is valuated reasonably with a Price/Forward Earnings ratio of 10.61.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IMD indicates a rather cheap valuation: IMD is cheaper than 85.25% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of IMD to the average of the S&P500 Index (34.98), we can say IMD is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.75 | ||
| Fwd PE | 10.61 |
4.2 Price Multiples
IMD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IMD is cheaper than 83.61% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, IMD is valued cheaply inside the industry as 90.16% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.82 | ||
| EV/EBITDA | 8.81 |
4.3 Compensation for Growth
A cheap valuation may be justified as IMD's earnings are expected to decrease with -6.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.25%
EPS Next 3Y-6.27%
5. Dividend
5.1 Amount
IMD has a Yearly Dividend Yield of 6.90%, which is a nice return.
The stock price of IMD dropped by -24.43% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 2.11, IMD pays a better dividend. On top of this IMD pays more dividend than 98.36% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, IMD pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.9% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
IMD pays out 212.93% of its income as dividend. This is not a sustainable payout ratio.
DP212.93%
EPS Next 2Y-9.25%
EPS Next 3Y-6.27%
BIT:IMD (11/3/2025, 7:00:00 PM)
1.5
-0.02 (-1.32%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners1.94%
Inst Owner ChangeN/A
Ins Owners75.51%
Ins Owner ChangeN/A
Market Cap26.48M
Revenue(TTM)36.29M
Net Income(TTM)1.34M
Analysts45.71
Price Target1.53 (2%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.9% |
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP212.93%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-24.62%
PT rev (3m)-24.62%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-56.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.75 | ||
| Fwd PE | 10.61 | ||
| P/S | 0.73 | ||
| P/FCF | 11.82 | ||
| P/OCF | 9.1 | ||
| P/B | 1.2 | ||
| P/tB | 1.28 | ||
| EV/EBITDA | 8.81 |
EPS(TTM)0.08
EY5.33%
EPS(NY)0.14
Fwd EY9.43%
FCF(TTM)0.13
FCFY8.46%
OCF(TTM)0.16
OCFY10.99%
SpS2.06
BVpS1.25
TBVpS1.17
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.5
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.04% | ||
| ROE | 6.09% | ||
| ROCE | 7.08% | ||
| ROIC | 4.85% | ||
| ROICexc | 6.32% | ||
| ROICexgc | 6.81% | ||
| OM | 4.83% | ||
| PM (TTM) | 3.7% | ||
| GM | 24.88% | ||
| FCFM | 6.17% |
ROA(3y)7.1%
ROA(5y)N/A
ROE(3y)13.65%
ROE(5y)N/A
ROIC(3y)12.28%
ROIC(5y)N/A
ROICexc(3y)15.57%
ROICexc(5y)N/A
ROICexgc(3y)16.37%
ROICexgc(5y)N/A
ROCE(3y)17.89%
ROCE(5y)N/A
ROICexgc growth 3Y-23.19%
ROICexgc growth 5YN/A
ROICexc growth 3Y-24.4%
ROICexc growth 5YN/A
OM growth 3Y-15.05%
OM growth 5YN/A
PM growth 3Y-13.98%
PM growth 5YN/A
GM growth 3Y-1.7%
GM growth 5YN/A
F-Score6
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.19 | ||
| Debt/EBITDA | 0.1 | ||
| Cap/Depr | 104.88% | ||
| Cap/Sales | 1.85% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 121.64% | ||
| Profit Quality | 167.02% | ||
| Current Ratio | 3.53 | ||
| Quick Ratio | 1.74 | ||
| Altman-Z | 4.04 |
F-Score6
WACC8.02%
ROIC/WACC0.61
Cap/Depr(3y)149.51%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.29%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-48.43%
EPS 3Y-17.97%
EPS 5YN/A
EPS Q2Q%-66.28%
EPS Next Y-23.53%
EPS Next 2Y-9.25%
EPS Next 3Y-6.27%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.61%
Revenue growth 3Y-5.22%
Revenue growth 5YN/A
Sales Q2Q%-15.36%
Revenue Next Year0.61%
Revenue Next 2Y1.52%
Revenue Next 3Y1.81%
Revenue Next 5YN/A
EBIT growth 1Y-52.97%
EBIT growth 3Y-19.48%
EBIT growth 5YN/A
EBIT Next Year-3.63%
EBIT Next 3Y-1.22%
EBIT Next 5YN/A
FCF growth 1Y354.49%
FCF growth 3Y32.27%
FCF growth 5YN/A
OCF growth 1Y712.77%
OCF growth 3Y35.57%
OCF growth 5YN/A
IMD INTERNATIONAL MEDICAL DE / IMD.MI FAQ
What is the ChartMill fundamental rating of IMD INTERNATIONAL MEDICAL DE (IMD.MI) stock?
ChartMill assigns a fundamental rating of 5 / 10 to IMD.MI.
What is the valuation status of IMD INTERNATIONAL MEDICAL DE (IMD.MI) stock?
ChartMill assigns a valuation rating of 6 / 10 to IMD INTERNATIONAL MEDICAL DE (IMD.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for IMD INTERNATIONAL MEDICAL DE?
IMD INTERNATIONAL MEDICAL DE (IMD.MI) has a profitability rating of 3 / 10.
What are the PE and PB ratios of IMD INTERNATIONAL MEDICAL DE (IMD.MI) stock?
The Price/Earnings (PE) ratio for IMD INTERNATIONAL MEDICAL DE (IMD.MI) is 18.75 and the Price/Book (PB) ratio is 1.2.
Can you provide the expected EPS growth for IMD stock?
The Earnings per Share (EPS) of IMD INTERNATIONAL MEDICAL DE (IMD.MI) is expected to decline by -23.53% in the next year.